D. Baker

发表

Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.

A. Gottlieb, M. Bala, A. Menter, 2004, Journal of the American Academy of Dermatology.

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

D. M. van der Heijde, P. Emery, E. Keystone, 2004, Arthritis and rheumatism.

Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.

D. M. van der Heijde, H. Houben, R. Landewé, 2008, Arthritis and rheumatism.

Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients.

J. Smolen, D. Aletaha, J. Funovits, 2009, Rheumatology.

Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.

J. Kremer, P. Taylor, C. Ritchlin, 2010, Arthritis and rheumatism.

Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.

John Han, Daniel Baker, Paul Emery, 2006, Arthritis and rheumatism.

Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis

A. Kavanaugh, J. Smolen, D. Aletaha, 2010, Annals of the rheumatic diseases.

A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate

J. Smolen, A. Greenspan, D. Baker, 2015, Annals of the rheumatic diseases.

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade

D. M. van der Heijde, M. Bala, P. Emery, 2008, Annals of the rheumatic diseases.

The effects of structural damage on functional disability in psoriatic arthritis

J. Smolen, D. Aletaha, D. Baker, 2017, Annals of the rheumatic diseases.

Association of anemia and physical disability among patients with rheumatoid arthritis.

Mahboob Rahman, M. Bala, A. Kavanaugh, 2007, The Journal of rheumatology.

The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases

Mahboob Rahman, D. M. van der Heijde, M. Bala, 2007, Arthritis research & therapy.

Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis

Stanley B. Cohen, Mahboob Rahman, G. Shankar, 2007, Journal of clinical pharmacology.

Diversity and Clonality of T Cell Receptor Repertoire and Antigen Specificities in Small Joints of Early Rheumatoid Arthritis

J. Reumers, Lars Klareskog, E. af Klint, 2022, Arthritis & rheumatology.

Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis.

M. Bala, A. Kavanaugh, Chenglong Han, 2008, Arthritis and rheumatism.

Infliximab treatment maintains employability in patients with early rheumatoid arthritis.

D. M. van der Heijde, M. Bala, P. Emery, 2006, Arthritis and rheumatism.

Ustekinumab: Lessons Learned from Targeting Interleukin‐12/23p40 in Immune‐Mediated Diseases

D. Baker, D. Baker, C. Brodmerkel, 2009, Annals of the New York Academy of Sciences.

Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.

B. Dijkmans, P. Geusens, A. Deodhar, 2008, Arthritis and rheumatism.

Effect of a nonsteroidal antiinflammatory drug on synovial fluid in osteoarthritis.

H. Schumacher, J. Baker, D. Baker, 1996, The Journal of rheumatology.

Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks

H. Yamanaka, N. Miyasaka, T. Koike, 2012, Annals of the rheumatic diseases.

The Effect of Intravenous Golimumab on Health-related Quality of Life in Rheumatoid Arthritis: 24-week Results of the Phase III GO-FURTHER Trial

M. Weinblatt, Chenglong Han, C. Bingham, 2014, The Journal of Rheumatology.

Population Pharmacokinetics of Golimumab, an Anti‐Tumor Necrosis Factor‐α Human Monoclonal Antibody, in Patients With Psoriatic Arthritis

C. Wagner, Honghui Zhou, T. Vu, 2009, Journal of clinical pharmacology.

MRI infl ammation at the vertebral unit only marginally predicts new syndesmophyte formation : a multilevel analysis in patients with ankylosing spondylitis

R. Landewé, D. Heijde, P. Machado, 2011 .

Double-blinded infliximab dose escalation in patients with rheumatoid arthritis

Mahboob Rahman, P. Geusens, C. Wagner, 2007, Annals of the rheumatic diseases.

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor

R. Landewé, P. Machado, B. Hsu, 2012, Annals of the rheumatic diseases.